ClinicalTrials.gov
public full text
Public Domain
Early FDG PET in Melanoma
Adult patients with histologically proven melanoma who will be treated with pembrolizumab will undergo FDG PET/CT scan as an early evaluation of response to therapy. Changes in FDG uptake will be correlated with lab and pathology results.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy#1087175
- Biological Therapy in Treating Patients With Metastatic Melanoma#329503
- Pre-Clinical White Matter Changes and Associated Connectivity Effects in Fabry Disease#807726
- CD147 Targeting Peptide Probe for PET Imaging in Solid Tumors#887523
- PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy#325287
Record · ID 859784
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive